Inflammatory Bowel Disease

Every day, millions of people around the world are challenged by debilitating diseases that are the result of an imbalance in the immune system. At Janssen, we are focusing our scientific expertise on restoring immune balance and advancing the discovery and development of new medicines that will redefine the way we approach immune-mediated inflammatory diseases.

We are driven by our commitment to people living with IBD, working side-by-side with healthcare stakeholders, to offer solutions based on trust and transparency.

Our mission is clear, and we will not rest until we achieve a world where immune-mediated inflammatory disease is a thing of the past.

My IBD Journey

My IBD Journey offers guidance on how to plan and manage the range of symptoms you may encounter as an individual living with Inflammatory Bowel Disease (IBD), allowing you to live your life to the fullest.

Find out more


Kostopoulos, Ioannis V., et al. "Minimal residual disease in multiple myeloma: current landscape and future applications with immunotherapeutic approaches." Frontiers in Oncology 10. 2020; 860.